| Name | Title | Contact Details |
|---|
CenterLight Health System ranks among the nation`s leading resources for long-term residential and community-based health care. A voluntary, nonprofit organization, CenterLIght has made life better for tens of thousands of New Yorkers from all backgrounds and walks of life. It first opened its doors to the poor, chronically ill and disabled just after the First World War.
Genetics Squared is a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence and proprietary point-of-care equipment for the evaluation and management of cardiovascular disease.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Refeyn is a company that specializes in label-free single molecule imaging and mass measurement of biomolecules in solution using mass photometry technology.
King's Medical Company is a Hudson, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.